Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Search clinical trials for: LYB004 50µg
Total 0 results
Nothing found
Sponsors and Collaborators
wenbinlu
Remedy Institute
Australian Childhood Foundation
Sociedad Española de Arteriosclerosis
Health Holding Company, Hail Health Cluster, Saudi Arabia
Carlos III Health Institute
The Depressive and Bipolar Disorder Alternative Treatment Foundation
Resurge Therapeutics Inc.
Dr Gilles DUCHEIX/ Center of clinical pharmacology/CIC Inserm-501 - Investigator
Zhijun Sun
Kettering Foundation
Laboratoires Iprad-Vegebom
Méthodologie et Evaluation pour la Recherche clinique et Epidémiologique sur le VIH en Afrique (MEREVA)
Prader-Willi Syndrome Association of Australia
NATURAmedicatrix Sàrl
Brigham and Womens' Hospital, Center for Surgery and Public Health
Epicentre, Paris, France.
Sonogenix
Jain, Isha, B.A., Massachusetts General Hospital, Harvard Medical School
Paul W. Read, MD
View Full List
Medical Conditions
Neurobehavioral Manifestation
Stage III Childhood Anaplastic Large Cell Lymphoma
Malignant Tumor of Extrahepatic Bile Duct
Intervention Studies
Stroke Recrudescence
Apneic; Oxygenation
Mycobacterium Avium Complex Infections
Stage IIIB Esophageal Adenocarcinoma
Marginal Zone B-cell Lymphoma
Hernia,Ventral
Pregnancy; Accident
Psychoactive Substance Use
Cell Senescence
Escape Room Games and Role Playing Gamification
Relapsed/Refractory Diffuse Large B-cell Lymphoma
Adherence to In-Office Glaucoma Evaluation Appointment
Refractory B-Lineage Lymphoma
Spinocerebellar Ataxia Genotype Type 3
Ankle Trauma
Lymphoblastic Lymphoma
View Full List
Drug Interventions
ART-123
Triple therapy
Colecalciferol D3 (Vigantol Oil)
LINjeta U-100 Insulin
Optiva artificial tear by Allergan
Lansoprazole 15mg QD
Everolimus
Irinotecan
300 mg of caffeine citrate infusion
Epalrestat
Omeprazole 40 mg
Fenofibric acid 135mg
Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody
Gadoteridol (ProHance)
Fostamatinib
SBI-087
FRSW107
Low molecular weight Heparin as standard of care treatment
Fortum (Ceftazidime for injection USP) Glaxo Smith Kline Pharmaceuticals Limited
Oral Aztreonam
View Full List
CROs by country
Contract Research Organizations in Algeria
Contract Research Organizations in Australia
Contract Research Organizations in Belgium
Contract Research Organizations in Congo
Contract Research Organizations in Congo, DR of
Contract Research Organizations in Guatemala
Contract Research Organizations in India
Contract Research Organizations in Kuwait
Contract Research Organizations in Moldova
Contract Research Organizations in Rwanda
Contract Research Organizations in Sweden
Contract Research Organizations in Tanzania
Contract Research Organizations in United Kingdom
CRO list by country
CROs in Sweden
PRA Health Sciences
Scandinavian CRO
Pivotal
Aixial
Theradex Oncology AB
IQVIA
A+ Science
OPIS
Dokumeds
Biomapas
All CROs in Sweden
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe